These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Autosomal dominant striatonigral degeneration: a clinical, pathological, and biochemical study of a new genetic disorder. Rosenberg RN; Nyhan WL; Bay C Trans Am Neurol Assoc; 1976; 101():78-80. PubMed ID: 1028273 [No Abstract] [Full Text] [Related]
4. Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Rosenberg RN; Nyhan WL; Bay C; Shore P Neurology; 1976 Aug; 26(8):703-14. PubMed ID: 945867 [TBL] [Abstract][Full Text] [Related]
5. A case of late onset striatonigral degeneration. Przedborski S; Schiffmann SN; Monseu G; Maloteaux JM; Flament-Durand J Acta Neurol Belg; 1989; 89(1):29-37. PubMed ID: 2508411 [TBL] [Abstract][Full Text] [Related]
7. Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging. Lang AE; Curran T; Provias J; Bergeron C Can J Neurol Sci; 1994 Nov; 21(4):311-8. PubMed ID: 7533048 [TBL] [Abstract][Full Text] [Related]
8. Striatonigral degeneration response to levodopa therapy. Rajput AH; Kazi KH; Rozdilsky B J Neurol Sci; 1972 Jul; 16(3):331-41. PubMed ID: 5038888 [No Abstract] [Full Text] [Related]
9. Striatonigral degeneration. A case report and a review of the literature. van Leeuwen RB; Perquin WV Clin Neurol Neurosurg; 1988; 90(2):121-4. PubMed ID: 3061696 [TBL] [Abstract][Full Text] [Related]
10. Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report. Hughes AJ; Daniel SE; Lees AJ Mov Disord; 1991; 6(4):342-6. PubMed ID: 1758453 [TBL] [Abstract][Full Text] [Related]
11. [Secondary degeneration of the substantia nigra after cerebral infarctions including the striatum]. Ohe Y; Hayashi T; Uchino A; Tanahashi N Brain Nerve; 2013 Mar; 65(3):289-95. PubMed ID: 23475521 [TBL] [Abstract][Full Text] [Related]
12. Striatonigral degeneration: clinical, MRI, and pathologic correlation. O'Brien C; Sung JH; McGeachie RE; Lee MC Neurology; 1990 Apr; 40(4):710-1. PubMed ID: 2320250 [TBL] [Abstract][Full Text] [Related]
13. The neuropathological features of neuroacanthocytosis. Rinne JO; Daniel SE; Scaravilli F; Pires M; Harding AE; Marsden CD Mov Disord; 1994 May; 9(3):297-304. PubMed ID: 8041370 [TBL] [Abstract][Full Text] [Related]
19. Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration. De Volder AG; Francart J; Laterre C; Dooms G; Bol A; Michel C; Goffinet AM Ann Neurol; 1989 Aug; 26(2):239-47. PubMed ID: 2789014 [TBL] [Abstract][Full Text] [Related]
20. Case records of the Massachusetts General Hospital. Case 30-1992. Progressive neurodegenerative disease in a young boy. N Engl J Med; 1992 Jul; 327(4):261-8. PubMed ID: 1614467 [No Abstract] [Full Text] [Related] [Next] [New Search]